STOCK TITAN

[Form 4] Morningstar, Inc. Insider Trading Activity

Filing Impact
(High)
Filing Sentiment
(Very Negative)
Form Type
4
Rhea-AI Filing Summary

Morningstar, Inc. (MORN) Executive Chairman Joseph D. Mansueto reported multiple sales of Common Stock under a Rule 10b5-1 trading plan adopted November 15, 2024. The Form 4 shows eight sale transactions executed August 15, 18 and 19, 2025, totaling 21,750 shares disposed of at reported weighted-average prices ranging approximately from $258.03 to $261.035. Following those transactions the filing shows the reporting person directly beneficially owns 9,340,231 shares and indirectly beneficially owns 5,336,106 shares held by grantor retained annuity trusts plus 150,000 shares held in trusts for the benefit of his children. The filing notes the sales were effected pursuant to the 10b5-1 plan and provides ranges of execution prices for each grouped trade.

Joseph D. Mansueto, Presidente Esecutivo di Morningstar, Inc. (MORN), ha comunicato più vendite di Azioni Ordinarie nell'ambito di un piano di negoziazione ai sensi della Rule 10b5-1 adottato il 15 novembre 2024. Il Modulo 4 riporta otto operazioni di vendita eseguite il 15, 18 e 19 agosto 2025, per un totale di 21.750 azioni cedute a prezzi medi ponderati indicati approssimativamente tra $258,03 e $261,035. Dopo tali transazioni la dichiarazione indica che la persona segnalante detiene direttamente in modo beneficiario 9.340.231 azioni e detiene indirettamente in modo beneficiario 5.336.106 azioni tramite grantor retained annuity trusts, oltre a 150.000 azioni in trust a beneficio dei suoi figli. La comunicazione precisa che le vendite sono state effettuate in base al piano 10b5-1 e fornisce gli intervalli dei prezzi di esecuzione per ciascun gruppo di operazioni.

Joseph D. Mansueto, Presidente Ejecutivo de Morningstar, Inc. (MORN), informó varias ventas de Acciones Comunes bajo un plan de negociación conforme a la Regla 10b5-1 adoptado el 15 de noviembre de 2024. El Formulario 4 muestra ocho transacciones de venta ejecutadas los días 15, 18 y 19 de agosto de 2025, por un total de 21.750 acciones vendidas a precios ponderados promedios reportados aproximadamente entre $258,03 y $261,035. Tras esas operaciones, la presentación indica que la persona informante posee de forma beneficiaria directa 9.340.231 acciones y de forma beneficiaria indirecta 5.336.106 acciones mantenidas en grantor retained annuity trusts, además de 150.000 acciones en fideicomisos para beneficio de sus hijos. La presentación señala que las ventas se efectuaron conforme al plan 10b5-1 y proporciona los rangos de precios de ejecución para cada grupo de operaciones.

Morningstar, Inc.(MORN)의 집행 의장 Joseph D. Mansueto가 2024년 11월 15일 채택된 Rule 10b5-1 거래 계획에 따라 보통주 여러 건을 매도했다고 보고했습니다. Form 4에는 2025년 8월 15일, 18일 및 19일에 실행된 8건의 매도 거래가 기재되어 있으며, 총 21,750주가 처분되었고 보고된 가중평균 가격은 대략 $258.03~$261.035 수준으로 표시되어 있습니다. 해당 거래 후 제출 자료에 따르면 보고인은 직접적으로 수익적으로 9,340,231주를 보유하고 있고, grantor retained annuity trusts를 통해 간접적으로 5,336,106주를 보유하며 자녀들을 위한 신탁에 150,000주를 보유하고 있습니다. 제출서류에는 매도는 10b5-1 계획에 따라 이루어졌으며 각 그룹 거래별 실행 가격 범위가 제시되어 있다고 명시되어 있습니다.

Joseph D. Mansueto, président exécutif de Morningstar, Inc. (MORN), a déclaré plusieurs ventes d'actions ordinaires dans le cadre d'un plan de négociation conforme à la règle 10b5-1 adopté le 15 novembre 2024. Le formulaire 4 indique huit opérations de vente exécutées les 15, 18 et 19 août 2025, pour un total de 21 750 actions cédées à des prix moyens pondérés déclarés s'étendant approximativement de $258,03 à $261,035. À la suite de ces transactions, le dépôt indique que la personne déclarente détient directement à titre bénéficiaire 9 340 231 actions et de façon indirecte 5 336 106 actions détenues par des grantor retained annuity trusts, ainsi que 150 000 actions dans des trusts au bénéfice de ses enfants. Le dépôt précise que les ventes ont été effectuées en vertu du plan 10b5-1 et fournit les fourchettes de prix d'exécution pour chaque groupe de transactions.

Joseph D. Mansueto, Executive Chairman von Morningstar, Inc. (MORN), meldete mehrere Veräußerungen von Stammaktien im Rahmen eines am 15. November 2024 angenommenen Rule‑10b5‑1‑Handelsplans. Das Formular 4 weist acht Verkaufstransaktionen aus, die am 15., 18. und 19. August 2025 ausgeführt wurden und insgesamt 21.750 Aktien umfassen, die zu berichteten gewichteten Durchschnittspreisen von etwa $258,03 bis $261,035 veräußert wurden. Nach diesen Transaktionen gibt die Meldung an, dass die meldende Person direkt wirtschaftlich 9.340.231 Aktien besitzt und indirekt wirtschaftlich 5.336.106 Aktien hält, die in grantor retained annuity trusts verwaltet werden, sowie 150.000 Aktien in Trusts zugunsten seiner Kinder. Die Meldung weist darauf hin, dass die Verkäufe gemäß dem 10b5‑1‑Plan erfolgten und nennt für jede gruppierte Transaktion die Ausführungspreisspannen.

Positive
  • Sales conducted under a Rule 10b5-1 trading plan, indicating pre-established execution and compliance with trading rules
  • Detailed disclosure of post-transaction beneficial ownership including direct and indirect holdings and trustee roles
  • Commitment to provide full execution details upon request, enhancing transparency about trade prices and quantities
Negative
  • Executive Chairman sold 21,750 shares in August 2025, which is an insider disposition disclosed to the market
  • Multiple sales over consecutive days may prompt investor questions about timing, though filed as 10b5-1 transactions

Insights

TL;DR Executive Chairman sold 21,750 shares under a pre-established 10b5-1 plan; remaining direct and indirect holdings remain substantial.

The Form 4 reveals structured disposition activity: eight sell transactions on August 15, 18 and 19, 2025, executed under a Rule 10b5-1 plan adopted November 15, 2024. The filings disclose weighted-average sale prices for grouped trades and state the precise post-transaction beneficial ownership totals: 9,340,231 shares directly and 5,486,106 shares indirectly via trusts. From an investor-analysis perspective, the record shows compliance with an established plan and transparency on execution price ranges, but it does not include any company performance data or reasons for the trust holdings and dispositions.

TL;DR Transactions were executed under a documented 10b5-1 plan and the filer disclosed trust ownership and trustee roles.

The report documents that the sales were made pursuant to a 10b5-1 trading plan, which provides an affirmative defense under Rule 10b5-1 when conditions are met. The filing also discloses the nature of indirect holdings: grantor retained annuity trusts for the reporting person and trusts for his children, and identifies trustees. The Form 4 includes undertaking language offering to supply detailed execution data upon request, supporting transparency. The filing does not allege any change in officer or director status.

Joseph D. Mansueto, Presidente Esecutivo di Morningstar, Inc. (MORN), ha comunicato più vendite di Azioni Ordinarie nell'ambito di un piano di negoziazione ai sensi della Rule 10b5-1 adottato il 15 novembre 2024. Il Modulo 4 riporta otto operazioni di vendita eseguite il 15, 18 e 19 agosto 2025, per un totale di 21.750 azioni cedute a prezzi medi ponderati indicati approssimativamente tra $258,03 e $261,035. Dopo tali transazioni la dichiarazione indica che la persona segnalante detiene direttamente in modo beneficiario 9.340.231 azioni e detiene indirettamente in modo beneficiario 5.336.106 azioni tramite grantor retained annuity trusts, oltre a 150.000 azioni in trust a beneficio dei suoi figli. La comunicazione precisa che le vendite sono state effettuate in base al piano 10b5-1 e fornisce gli intervalli dei prezzi di esecuzione per ciascun gruppo di operazioni.

Joseph D. Mansueto, Presidente Ejecutivo de Morningstar, Inc. (MORN), informó varias ventas de Acciones Comunes bajo un plan de negociación conforme a la Regla 10b5-1 adoptado el 15 de noviembre de 2024. El Formulario 4 muestra ocho transacciones de venta ejecutadas los días 15, 18 y 19 de agosto de 2025, por un total de 21.750 acciones vendidas a precios ponderados promedios reportados aproximadamente entre $258,03 y $261,035. Tras esas operaciones, la presentación indica que la persona informante posee de forma beneficiaria directa 9.340.231 acciones y de forma beneficiaria indirecta 5.336.106 acciones mantenidas en grantor retained annuity trusts, además de 150.000 acciones en fideicomisos para beneficio de sus hijos. La presentación señala que las ventas se efectuaron conforme al plan 10b5-1 y proporciona los rangos de precios de ejecución para cada grupo de operaciones.

Morningstar, Inc.(MORN)의 집행 의장 Joseph D. Mansueto가 2024년 11월 15일 채택된 Rule 10b5-1 거래 계획에 따라 보통주 여러 건을 매도했다고 보고했습니다. Form 4에는 2025년 8월 15일, 18일 및 19일에 실행된 8건의 매도 거래가 기재되어 있으며, 총 21,750주가 처분되었고 보고된 가중평균 가격은 대략 $258.03~$261.035 수준으로 표시되어 있습니다. 해당 거래 후 제출 자료에 따르면 보고인은 직접적으로 수익적으로 9,340,231주를 보유하고 있고, grantor retained annuity trusts를 통해 간접적으로 5,336,106주를 보유하며 자녀들을 위한 신탁에 150,000주를 보유하고 있습니다. 제출서류에는 매도는 10b5-1 계획에 따라 이루어졌으며 각 그룹 거래별 실행 가격 범위가 제시되어 있다고 명시되어 있습니다.

Joseph D. Mansueto, président exécutif de Morningstar, Inc. (MORN), a déclaré plusieurs ventes d'actions ordinaires dans le cadre d'un plan de négociation conforme à la règle 10b5-1 adopté le 15 novembre 2024. Le formulaire 4 indique huit opérations de vente exécutées les 15, 18 et 19 août 2025, pour un total de 21 750 actions cédées à des prix moyens pondérés déclarés s'étendant approximativement de $258,03 à $261,035. À la suite de ces transactions, le dépôt indique que la personne déclarente détient directement à titre bénéficiaire 9 340 231 actions et de façon indirecte 5 336 106 actions détenues par des grantor retained annuity trusts, ainsi que 150 000 actions dans des trusts au bénéfice de ses enfants. Le dépôt précise que les ventes ont été effectuées en vertu du plan 10b5-1 et fournit les fourchettes de prix d'exécution pour chaque groupe de transactions.

Joseph D. Mansueto, Executive Chairman von Morningstar, Inc. (MORN), meldete mehrere Veräußerungen von Stammaktien im Rahmen eines am 15. November 2024 angenommenen Rule‑10b5‑1‑Handelsplans. Das Formular 4 weist acht Verkaufstransaktionen aus, die am 15., 18. und 19. August 2025 ausgeführt wurden und insgesamt 21.750 Aktien umfassen, die zu berichteten gewichteten Durchschnittspreisen von etwa $258,03 bis $261,035 veräußert wurden. Nach diesen Transaktionen gibt die Meldung an, dass die meldende Person direkt wirtschaftlich 9.340.231 Aktien besitzt und indirekt wirtschaftlich 5.336.106 Aktien hält, die in grantor retained annuity trusts verwaltet werden, sowie 150.000 Aktien in Trusts zugunsten seiner Kinder. Die Meldung weist darauf hin, dass die Verkäufe gemäß dem 10b5‑1‑Plan erfolgten und nennt für jede gruppierte Transaktion die Ausführungspreisspannen.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Mansueto Joseph D

(Last) (First) (Middle)
22 W. WASHINGTON

(Street)
CHICAGO IL 60602

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Morningstar, Inc. [ MORN ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director X 10% Owner
X Officer (give title below) Other (specify below)
Executive Chairman
3. Date of Earliest Transaction (Month/Day/Year)
08/15/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 08/15/2025 S(1) 6,040 D $258.5138(2) 9,355,941 D
Common Stock 08/15/2025 S(1) 1,208 D $259.3171(3) 9,354,733 D
Common Stock 08/15/2025 S(1) 2 D $260.68 9,354,731 D
Common Stock 08/18/2025 S(1) 6,846 D $258.0309(4) 9,347,885 D
Common Stock 08/18/2025 S(1) 404 D $258.825(5) 9,347,481 D
Common Stock 08/19/2025 S(1) 2,757 D $258.9593(6) 9,344,724 D
Common Stock 08/19/2025 S(1) 3,577 D $259.8268(7) 9,341,147 D
Common Stock 08/19/2025 S(1) 916 D $260.5706(8) 9,340,231 D
Common Stock 5,336,106 I By Trust(9)
Common Stock 150,000 I By Trust(10)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 15, 2024.
2. The transaction was executed in multiple trades at prices ranging from $258.0800 to $259.0745. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, Morningstar or a shareholder of Morningstar full information regarding the number of shares and prices at which the transaction was effected.
3. The transaction was executed in multiple trades at prices ranging from $259.0808 to $259.5500. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, Morningstar or a shareholder of Morningstar full information regarding the number of shares and prices at which the transaction was effected.
4. The transaction was executed in multiple trades at prices ranging from $257.6300 to $258.6100. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, Morningstar or a shareholder of Morningstar full information regarding the number of shares and prices at which the transaction was effected.
5. The transaction was executed in multiple trades at prices ranging from $258.6500 to $258.9700. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, Morningstar or a shareholder of Morningstar full information regarding the number of shares and prices at which the transaction was effected.
6. The transaction was executed in multiple trades at prices ranging from $258.3250 to $259.2900. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, Morningstar or a shareholder of Morningstar full information regarding the number of shares and prices at which the transaction was effected.
7. The transaction was executed in multiple trades at prices ranging from $259.3400 to $260.3200. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, Morningstar or a shareholder of Morningstar full information regarding the number of shares and prices at which the transaction was effected.
8. The transaction was executed in multiple trades at prices ranging from $260.3450 to $261.0350. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, Morningstar or a shareholder of Morningstar full information regarding the number of shares and prices at which the transaction was effected.
9. The shares are held in grantor retained annuity trusts for the benefit of the reporting person and his children. The reporting person serves as trustee of the grantor retained annuity trusts.
10. The shares are held in trusts for the benefit of the reporting person's children. The reporting person's spouse is trustee of the trusts.
Remarks:
/s/ Kathleen Peacock, by power of attorney 08/19/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Joseph D. Mansueto disclose on the Form 4 for MORN?

The Form 4 reports multiple sales of Common Stock on 08/15/2025, 08/18/2025 and 08/19/2025 totaling 21,750 shares, executed under a Rule 10b5-1 plan.

How many Morningstar (MORN) shares does the reporting person own after these transactions?

The filing shows 9,340,231 shares directly beneficially owned and 5,336,106 shares indirectly held in grantor retained annuity trusts, plus 150,000 shares in trusts for his children.

Were the August 2025 sales part of a predetermined trading plan?

Yes. The sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 15, 2024.

At what prices were the MORN shares sold?

The filing reports weighted-average prices for grouped trades with execution price ranges for each sale, approximately between $257.63 and $261.035.

Who signed the Form 4 for the reporting person?

The Form 4 was signed by Kathleen Peacock, by power of attorney on 08/19/2025.
Morningstar

NASDAQ:MORN

MORN Rankings

MORN Latest News

MORN Latest SEC Filings

MORN Stock Data

10.98B
23.23M
44.87%
61.91%
1.22%
Financial Data & Stock Exchanges
Investment Advice
Link
United States
CHICAGO